Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

1.

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Kvartsberg H, Duits FH, Ingelsson M, Andreasen N, Öhrfelt A, Andersson K, Brinkmalm G, Lannfelt L, Minthon L, Hansson O, Andreasson U, Teunissen CE, Scheltens P, Van der Flier WM, Zetterberg H, Portelius E, Blennow K.

Alzheimers Dement. 2014 Dec 19. pii: S1552-5260(14)02863-5. doi: 10.1016/j.jalz.2014.10.009. [Epub ahead of print]

PMID:
25533203
[PubMed - as supplied by publisher]
2.

Predicting progression from cognitive impairment to Alzheimer's disease with the disease state index.

Hall A, Mattila J, Koikkalainen J, Lotjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frolich L, Hampel H, Visser PJ, Soininen H.

Curr Alzheimer Res. 2015;12(1):69-79.

PMID:
25523428
[PubMed - in process]
3.

An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.

Hölttä M, Minthon L, Hansson O, Holmén-Larsson J, Pike I, Ward M, Kuhn K, Rüetschi U, Zetterberg H, Blennow K, Gobom J.

J Proteome Res. 2014 Dec 22. [Epub ahead of print]

PMID:
25490617
[PubMed - as supplied by publisher]
4.

Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.

Wattmo C, Londos E, Minthon L.

Clin Interv Aging. 2014 Nov 14;9:1951-62. doi: 10.2147/CIA.S71709. eCollection 2014.

PMID:
25484578
[PubMed - in process]
Free PMC Article
5.

Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function.

Kettunen P, Larsson S, Holmgren S, Olsson S, Minthon L, Zetterberg H, Blennow K, Nilsson S, Sjölander A.

J Alzheimers Dis. 2014 Nov 24. [Epub ahead of print]

PMID:
25420549
[PubMed - as supplied by publisher]
6.

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.

Brinkmalm A, Brinkmalm G, Honer WG, Frölich L, Hausner L, Minthon L, Hansson O, Wallin A, Zetterberg H, Blennow K, Öhrfelt A.

Mol Neurodegener. 2014 Nov 23;9:53. doi: 10.1186/1750-1326-9-53.

PMID:
25418885
[PubMed - in process]
Free PMC Article
7.

Pro-inflammatory cytokines reduce the proliferation of NG2 cells and increase shedding of NG2 in vivo and in vitro.

Wennström M, Janelidze S, Bay-Richter C, Minthon L, Brundin L.

PLoS One. 2014 Oct 6;9(10):e109387. doi: 10.1371/journal.pone.0109387. eCollection 2014.

PMID:
25285951
[PubMed - in process]
Free PMC Article
8.

Nonlinear association between pulse wave velocity and cognitive function: a population-based study.

Nilsson ED, Elmståhl S, Minthon L, Nilsson PM, Pihlsgård M, Tufvesson E, Nägga K.

J Hypertens. 2014 Nov;32(11):2152-7; discussion 2157. doi: 10.1097/HJH.0000000000000329.

PMID:
25275244
[PubMed - in process]
9.

Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.

Janelidze S, Suchankova P, Ekman A, Erhardt S, Sellgren C, Samuelsson M, Westrin A, Minthon L, Hansson O, Träskman-Bendz L, Brundin L.

Acta Psychiatr Scand. 2014 Sep 24. doi: 10.1111/acps.12339. [Epub ahead of print]

PMID:
25251027
[PubMed - as supplied by publisher]
10.

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.

Wattmo C, Londos E, Minthon L.

BMC Neurol. 2014 Sep 10;14:173. doi: 10.1186/s12883-014-0173-4.

PMID:
25213579
[PubMed - in process]
Free PMC Article
11.

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.

PMID:
25162367
[PubMed - indexed for MEDLINE]
12.

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.

Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.

JAMA Neurol. 2014 Oct;71(10):1282-9. doi: 10.1001/jamaneurol.2014.1358.

PMID:
25155658
[PubMed - in process]
13.

Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia.

Nägga K, Hansson O, van Westen D, Minthon L, Wennström M.

J Alzheimers Dis. 2014;42(4):1435-41. doi: 10.3233/JAD-141200.

PMID:
25024336
[PubMed - in process]
14.

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.

Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E.

BMJ Open. 2014 Jul 3;4(7):e005158. doi: 10.1136/bmjopen-2014-005158.

PMID:
24993765
[PubMed - in process]
Free PMC Article
15.

Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up.

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2014;38(5-6):286-99. doi: 10.1159/000362926. Epub 2014 Jul 3.

PMID:
24992891
[PubMed - in process]
16.

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, Minthon L, Nägga K, Londos E, Varghese S, Majbour NK, Al-Hayani A, El-Agnaf OM.

Alzheimers Res Ther. 2014 May 7;6(3):25. doi: 10.1186/alzrt255. eCollection 2014.

PMID:
24987465
[PubMed]
Free PMC Article
17.

Involvement of matrix metalloproteinase-9 in amyloid-β 1-42-induced shedding of the pericyte proteoglycan NG2.

Schultz N, Nielsen HM, Minthon L, Wennström M.

J Neuropathol Exp Neurol. 2014 Jul;73(7):684-92. doi: 10.1097/NEN.0000000000000084.

PMID:
24918635
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.

Wennström M, Nielsen HM, Orhan F, Londos E, Minthon L, Erhardt S.

Int J Tryptophan Res. 2014 Apr 28;7:1-7. doi: 10.4137/IJTR.S13958. eCollection 2014.

PMID:
24855376
[PubMed]
Free PMC Article
19.

Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.

Bengtsson-Lindberg M, Larsson V, Minthon L, Wattmo C, Londos E.

Clin Auton Res. 2014 Apr 18. [Epub ahead of print]

PMID:
24743866
[PubMed - as supplied by publisher]
20.

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Nov;10(6):713-723.e2. doi: 10.1016/j.jalz.2013.12.023. Epub 2014 Apr 8.

PMID:
24721526
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk